Two Oral GLP-1s Increase Options for Patient Care - Medscape
Two Oral GLP-1s Increase Options for Patient Care Medscape
Semaglutide News
Ozempic Shows Startling New Side Effect, Says Massive Study - Newsweek
Ozempic Shows Startling New Side Effect, Says Massive Study Newsweek
NHS England to offer weight-loss drugs to 1.2m people to reduce risk of heart attacks and strokes - The Guardian
NHS England to offer weight-loss drugs to 1.2m people to reduce risk of heart attacks and strokes The Guardian
Hims & Hers Announces Strategic Shift for US Weight Loss Business - HIMS Investor Relations
Hims & Hers Announces Strategic Shift for US Weight Loss Business HIMS Investor Relations
India is launching cheap weight-loss drugs — but Novo Nordisk is betting its brands will stay on top - CNBC
India is launching cheap weight-loss drugs — but Novo Nordisk is betting its brands will stay on top CNBC
Semaglutide May Reverse Damage Caused by Osteoarthritis, Study Suggests - sciencealert.com
Semaglutide May Reverse Damage Caused by Osteoarthritis, Study Suggests sciencealert.com
Ozempic, Wegovy: India's cheap weight-loss drugs could reshape global obesity fight - BBC
Ozempic, Wegovy: India's cheap weight-loss drugs could reshape global obesity fight BBC
Bimagrumab plus semaglutide alone or in combination for the treatment of obesity: a randomized phase 2 trial - Nature
Bimagrumab plus semaglutide alone or in combination for the treatment of obesity: a randomized phase 2 trial Nature
Canadian company seeks to stand out with domestically-made generic Ozempic - CBC
Canadian company seeks to stand out with domestically-made generic Ozempic CBC
Head-to-head trial pitting Eli Lilly’s oral GLP-1 against oral semaglutide underscores efficacy of weight-loss pills - Scientific American
Head-to-head trial pitting Eli Lilly’s oral GLP-1 against oral semaglutide underscores efficacy of weight-loss pills Scientific American
Oral Semaglutide Demonstrates Greater Weight Loss Versus Orforglipron in Indirect Comparison - Pharmacy Times
Oral Semaglutide Demonstrates Greater Weight Loss Versus Orforglipron in Indirect Comparison Pharmacy Times
Wegovy HD 7.2mg Now Available for Chronic Weight Management - Medical Professionals Reference
Wegovy HD 7.2mg Now Available for Chronic Weight Management Medical Professionals Reference
Novo Nordisk's Wegovy® HD available now nationwide - PR Newswire
Novo Nordisk's Wegovy® HD available now nationwide PR Newswire
Indirect Analysis Suggests Greater Weight Loss With Oral Semaglutide vs Orforglipron - HCPLive
Indirect Analysis Suggests Greater Weight Loss With Oral Semaglutide vs Orforglipron HCPLive
Medicine Box | How is semaglutide made? OneSource MD Neeraj Sharma explains the semaglutide manufacturing process, from formulation to final production. In conversation with Ekta Batra, he breaks down the science behind this widely used diabetes and - LinkedIn
Medicine Box | How is semaglutide made? OneSource MD Neeraj Sharma explains the semaglutide manufacturing process, from formulation to final production. In conversation with Ekta Batra, he breaks down the science behind this widely used diabetes and LinkedIn
Wegovy HD Now Available in the U.S. - Pharmaceutical Executive
Wegovy HD Now Available in the U.S. Pharmaceutical Executive
Study Looks at Weight Gain After Stopping GLP-1 Medication - The Well News
Study Looks at Weight Gain After Stopping GLP-1 Medication The Well News
Semaglutide is going off-patent in India. But will people who need it be able to get it? - statnews.com
Semaglutide is going off-patent in India. But will people who need it be able to get it? statnews.com
More Than One Million People to be Offered Semaglutide on NHS - European Medical Journal
More Than One Million People to be Offered Semaglutide on NHS European Medical Journal
Coming off GLP 1s - The Medical University of South Carolina
Coming off GLP 1s The Medical University of South Carolina
Semaglutide Shows Surprising Mental Health Benefits in Massive 100,000-Person Study - SciTechDaily
Semaglutide Shows Surprising Mental Health Benefits in Massive 100,000-Person Study SciTechDaily
GLP-1 Pill Showdown; $35 Insulin Cap Success; Preterm Births Tied to Plastics - MedPage Today
GLP-1 Pill Showdown; $35 Insulin Cap Success; Preterm Births Tied to Plastics MedPage Today
Semaglutide for weight loss was linked to a sharp drop in alcohol use in this case report - News-Medical
Semaglutide for weight loss was linked to a sharp drop in alcohol use in this case report News-Medical
Novo Nordisk plans to cut price of Ozempic as generics hit market - ET Pharma
Novo Nordisk plans to cut price of Ozempic as generics hit market ET Pharma
Higher-Dose Semaglutide Approved Under New FDA Accelerated Review Process - The American Journal of Managed Care® (AJMC®)
Higher-Dose Semaglutide Approved Under New FDA Accelerated Review Process The American Journal of Managed Care® (AJMC®)
Oral Alternative to Ozempic May Be Even More Effective For Weight Loss - sciencealert.com
Oral Alternative to Ozempic May Be Even More Effective For Weight Loss sciencealert.com
Wegovy® pill demonstrated greater weight loss than orforglipron and lower odds of stopping medication due to side effects in a new indirect comparison to be presented at Obesity Medicine Association 2026 - PR Newswire
Wegovy® pill demonstrated greater weight loss than orforglipron and lower odds of stopping medication due to side effects in a new indirect comparison to be presented at Obesity Medicine Association 2026 PR Newswire
Wegovy® (semaglutide injection) 2.4 mg recommended by NICE to reduce risk of major adverse cardiovascular events, including heart attacks and strokes, in adults with established cardiovascular disease and overweight or obesity (BMI ≥ 27 kg/m2) - News-Medical
Wegovy® (semaglutide injection) 2.4 mg recommended by NICE to reduce risk of major adverse cardiovascular events, including heart attacks and strokes, in adults with established cardiovascular disease and overweight or obesity (BMI ≥ 27 kg/m2) News-Medical
The ‘astounding’ rise of semaglutide — and what’s next for weight-loss drugs - Nature
The ‘astounding’ rise of semaglutide — and what’s next for weight-loss drugs Nature
FDA warns consumers not to use counterfeit Ozempic (semaglutide) found in U.S. drug supply chain - fda.gov
FDA warns consumers not to use counterfeit Ozempic (semaglutide) found in U.S. drug supply chain fda.gov
Higher dose of semaglutide increases weight loss, metabolic benefits: Newsroom - UT Southwestern Medical Center
Higher dose of semaglutide increases weight loss, metabolic benefits: Newsroom UT Southwestern Medical Center
Semaglutide Improves Knee Replacements for Patients with Diabetes - Yale School of Medicine
Semaglutide Improves Knee Replacements for Patients with Diabetes Yale School of Medicine
Oral Semaglutide Pills for Weight Management: What to Know - Cedars-Sinai
Oral Semaglutide Pills for Weight Management: What to Know Cedars-Sinai
FDA Approves Higher-Dose Semaglutide Under Accelerated Review Program - Pharmacy Times
FDA Approves Higher-Dose Semaglutide Under Accelerated Review Program Pharmacy Times
With Novo's semaglutide going off patent, Indian drugmakers set to launch their cheaper generics - Fierce Pharma
With Novo's semaglutide going off patent, Indian drugmakers set to launch their cheaper generics Fierce Pharma
Efficacy of GLP-1 analog peptides, semaglutide, tirzepatide, and retatrutide on MC4R deficient obesity and their comparison | International Journal of Obesity - Nature
Efficacy of GLP-1 analog peptides, semaglutide, tirzepatide, and retatrutide on MC4R deficient obesity and their comparison | International Journal of Obesity Nature
Oral Semaglutide and the GLP-1 Compounding Reckoning: From Regulatory Ambiguity to FDA Enforcement, DOJ Referrals, and Novo Nordisk’s Case Against Hims & Hers - Buchanan Ingersoll & Rooney
Oral Semaglutide and the GLP-1 Compounding Reckoning: From Regulatory Ambiguity to FDA Enforcement, DOJ Referrals, and Novo Nordisk’s Case Against Hims & Hers Buchanan Ingersoll & Rooney
Cardiovascular outcomes of semaglutide and tirzepatide for patients with type 2 diabetes in clinical practice - Nature
Cardiovascular outcomes of semaglutide and tirzepatide for patients with type 2 diabetes in clinical practice Nature
GLP-1 Pills vs. Shots: Which Is Easier, Cheaper, and More Effective for Weight Loss? - Health: Trusted and Empathetic Health and Wellness Information
GLP-1 Pills vs. Shots: Which Is Easier, Cheaper, and More Effective for Weight Loss? Health: Trusted and Empathetic Health and Wellness Information
Ozempic Is About to Go Generic for Billions of People - The New York Times
Ozempic Is About to Go Generic for Billions of People The New York Times